Accumulating evidence from meta-analyses of prognostic studies on oral cancer: towards biomarker-driven patient selection




Almangush, Alhadi; Alabi, Rasheed Omobolaji; Pirinen, Matti; Mäkitie, Antti; Leivo, Ilmo

PublisherBMC

LONDON

2024

BMC Cancer

BMC CANCER

BMC CANCER

1517

24

1

13

1471-2407

DOIhttps://doi.org/10.1186/s12885-024-13317-z

https://doi.org/10.1186/s12885-024-13317-z

https://research.utu.fi/converis/portal/detail/Publication/478088272



Background

Many histopathologic prognostic markers, identified by routine hematoxylin and eosin (HE) staining, have been proposed for predicting the survival of patients with oral squamous cell carcinoma (OSCC). Subsequently, several meta-analyses have been conducted on these prognostic markers. We sought to analyze the accumulated evidence from these meta-analyses.

Methods

An electronic database search of PubMed, Scopus, Ovid Medline, Web of Science, and Cochrane Library was conducted to retrieve all meta-analysis articles published on histopathologic prognostic markers of OSCC. The risk of bias of the included studies was analyzed using the Risk of Bias in Systematic Reviews (ROBIS) tool. The synthesis of the results was conducted following the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).

Results

There were 16 meta-analysis articles published on the histological prognostic markers of OSSC. The accumulated evidence from these meta-analyses highlighted the powerful prognostic value of depth of invasion, tumor thickness, perineural invasion, lymphovascular invasion, worst pattern of invasion, tumor budding, and tumor-stroma ratio. The highest odds ratio (OR) of a relationship between a histopathologic prognostic marker and outcome was for the depth of invasion (OR 10.16, 95% CI 5.05-20.46) and tumor thickness (OR 7.32, 95% CI 5.3-10.1) in predicting lymph node metastasis.

Conclusion

The published meta-analyses present robust evidence on the significance of emerging histopathologic markers, namely, worst pattern of invasion, tumor budding, and tumor-stroma ratio. It is time to consider such markers in daily pathology reporting and risk stratification of OSCC.


Open Access funding provided by University of Helsinki (including Helsinki University Central Hospital).

The authors acknowledge the funding of Finnish Cancer Society, the Turku University Hospital Fund, Finska Läkaresällskapet, Maritza and Reino Salonen Foundation, K. Albin Johansson Foundation, the Finnish Dental Society Apollonia, the Helsinki University Hospital Research Fund, and the Sigrid Jusélius Foundation. Open access funded by Helsinki University Library


Last updated on 2025-06-02 at 09:57